The National Cancer Institute, in 1998, sponsored a randomized, phase III, controlled trial of proteolytic enzyme therapy versus chemotherapy. Because most eligible patients refused random assignment, ...

RECENT reports have stressed the diagnostic value of measuring serum proteolytic activity in patients with pancreatitis and pancreatic carcinoma.1 2 3 4 Nardi,1 ...

Moreover, the description of anti-tumour proteolytic enzymes has stimulated the design of novel approaches to identify the relevant proteases that must be targeted in each individual cancer ...

In a bid to better understand how cancer cells power their explosive growth and spread, scientists at Johns Hopkins Medicine ...

The National Cancer Institute, in 1998, sponsored a randomized, phase III, controlled trial of proteolytic enzyme therapy versus chemotherapy. Because most eligible patients refused random assignment, ...